VDL PFAS “Forever Chemicals” Investigation
Migliaccio & Rathod LLP is investigating whether VDL sold waterproof cosmetic products containing PFAS (“forever chemicals”) while marketing those products as clean, […]
Etude PFAS “Forever Chemicals” Investigation
Migliaccio & Rathod LLP is investigating whether Etude sold waterproof cosmetic products containing PFAS (“forever chemicals”) while promoting those products as clean, […]
Innisfree PFAS “Forever Chemicals” Investigation
Migliaccio & Rathod LLP is investigating whether Innisfree sold waterproof cosmetic products containing PFAS (“forever chemicals”) while marketing its products as clean, […]
Laneige PFAS “Forever Chemicals” Investigation
Migliaccio & Rathod LLP is investigating whether Laneige sold waterproof cosmetic products containing intentionally added PFAS (“forever chemicals”) while simultaneously marketing those […]
Center for Life Resources Data Breach Investigation
Migliaccio & Rathod LLP is investigating the Center for Life Resources Data Breach, impacting over 10,000 individuals.
Kean University Data Breach Investigation
Migliaccio & Rathod LLP is investigating the possible Kean University Data Breach, impacting an undetermined number of individuals and their personal information.
Highline Community College Data Breach Investigation
Migliaccio & Rathod LLP is investigating the possible Highline Community College Data Breach, impacting an undetermined number of individuals.
Cabin Creek Health Systems Data Breach Investigation
Migliaccio & Rathod LLP is investigating the possible Cabin Creek Health Systems Data Breach, impacting an undetermined number of individuals.
George Washington University Hospital Facility Fee Investigation
Migliaccio & Rathod LLP is investigating whether George Washington University Hospital and GW Medical Faculty Associates failed to adequately disclose outpatient facility […]
Sibley Memorial Hospital Facility Fee Investigation
Migliaccio & Rathod LLP is investigating whether Sibley Memorial Hospital, part of Johns Hopkins Medicine, failed to adequately disclose outpatient facility fees […]